Interestingly, in Alzheimer's disease research, a similar observation was noted where the chronic treatment with sorafenib inhibited c-Raf and NF-κB in the brains of the aged APPswe mice [44]. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.